A bill that includes a provision co-authored by U.S. Sen. Susan Collins to lower drug prices awaits President Donald Trump’s signature. The provision, part of the Food and Drug Administration’s Reauthorization Act, seeks to keep prescription drug prices down by speeding up timelines and inspection procedures for the FDA’s review of applications for generic drug […]
Maine GOP leader’s ‘news’ website propels ethics watchdogs into uncharted territory
The lazy myth of the 'bought and paid for' politician
We have zero tolerance for plane crashes. Why not mass shootings?
History shows students’ activism on gun violence can really matter